Citicoline sodium injection and preparation method thereof

By using sorbitol and xylitol isotonic agents, dilute hydrochloric acid to adjust pH value and multi-component filtration technology, combined with ultrasonic treatment, the stability and safety of sodium citicoline injection have been solved, and high-quality medicines have been achieved Production.

CN118948756AInactive Publication Date: 2024-11-15ZHEJIANG CHENGYI PAHRMACEUTICAL
View PDF 4 Cites 0 Cited by

Patent Information

Application Number
CN202411027710.3
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-29
Publication Date
2024-11-15
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

The existing citicoline sodium injection has poor stability, visible foreign matter and insoluble impurities during production and storage, which affects the quality and safety of the drug.

Method used

Sorbitol and xylitol are used as isotonic agents, combined with dilute hydrochloric acid to adjust pH value and multi-branch filter filtration technology, combined with ultrasonic treatment and temperature control, stable sodium citicoline injection is prepared to reduce oxygen content and impurity generation.

Benefits of technology

It improves the stability and safety of sodium citicoline injection, extends storage time, reduces drug quality problems and drug use risks, and is suitable for large-scale production.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0004969023000000051
    Figure BDA0004969023000000051
  • Figure BDA0004969023000000101
    Figure BDA0004969023000000101
  • Figure BDA0004969023000000111
    Figure BDA0004969023000000111
Patent Text Reader

Abstract

The invention relates to the technical field of medicine preparation, in particular to a citicoline sodium injection and a preparation method thereof.The citicoline sodium injection comprises citicoline sodium, an isotonic agent, a pH regulator and water for injection, and the pH of the citicoline sodium injection ranges from 6.4 to 7.0. The invention also discloses a preparation method of the citicoline sodium injection. By adopting a reasonable injection formula and a unique preparation method, the problems that the citicoline sodium injection is unstable in property and easy to deteriorate in the production and storage processes are effectively solved, visible foreign matters and insoluble impurities in the injection are reduced, the medicine quality is improved, and the clinical application prospect is broad. The safety and the reliability of the citicoline sodium injection are improved.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of drug preparation, and in particular to a citicoline sodium injection and a preparation method thereof. Background Art

[0002] The chemical name of Citicoline Sodium is the monosodium salt of choline cytidine diphosphate, also known as Citicoline Sodium, which is a drug for improving cerebral blood circulation and a nootropic drug, and is a nucleoside derivative. It has the function of enhancing the brainstem reticular structure, especially the ascending reticular structure excitation system closely related to consciousness, and also has the function of enhancing the pyramidal system, thereby improving motor paralysis. In addition, Citicoline Sodium can also improve cerebral circulation, promote brain material metabolism by reducing cerebral blood flow resistance and enhancing cerebral blood flow, and has a certain effect on promoting brain function recovery and awakening. It is mainly used clinically to treat acute craniocerebral trauma and consciousness disorders after brain surgery. At present, injection is a commonly used dosage form of Citicoline Sodium. In order to adjust the osmotic pressure and ensure the safety of the drug, the prior art generally chooses to add glucose as an isotonic agent in the prescription.

[0003] Chinese patent CN104027304B discloses a sodium citicoline glucose injection, which comprises sodium citicoline, glucose, glycine, citric acid, and the remainder of water for injection, and the pH value of the injection is 5.5-5.6. The glycine and citric acid in the injection act as cosolvents and stabilizers for sodium citicoline, which can enhance product stability, reduce the generation of related substances, and improve the stability of the injection.

[0004] Chinese patent CN102144963B discloses a citicoline sodium glucose injection and its preparation process, which is composed of active ingredient citicoline sodium, isotonic glucose, stabilizer, pH regulator and water for injection. The invention has the advantages of improving the quality stability of citicoline sodium glucose injection and the safety and effectiveness of the drug, which is conducive to the long-term storage of the drug. The invention effectively solves the problem of thermal instability and excessive related substances in citicoline sodium glucose injection during production and storage by adding a stabilizer to the injection.

[0005] However, the applicant has found that glucose may cause an increase in the content of 5-hydroxymethylfurfural (5-HMF) under long-term storage or heating conditions in liquid preparations. Studies have shown that it has certain irritation to the eyes, mucous membranes, and skin, and has neurotoxicity and genotoxicity. In addition, 5-HMF can be metabolized into 5-sulfinylmethylfurfural (5-SMF) in the body. 5-SMF has strong carcinogenicity and genotoxicity, which is not conducive to drug safety. In addition, in order to control the factors that affect the stability of citicoline sodium injection, such as pyrogens, microorganisms, and endotoxins in the liquid medicine, activated carbon filtration or the addition of excipients such as antibacterial agents, stabilizers, and cosolvents are usually used in the production process of citicoline sodium injection, which is very easy to produce visible foreign matter and incompatible particles, which not only affects the quality of the drug, but also may cause adverse reactions to the drug, increase the risk of medication, and is not conducive to drug safety. Summary of the invention

[0006] In view of the above-mentioned defects of the prior art, the present invention provides a citicoline sodium injection. The present invention adopts a reasonable injection formula and a unique preparation method, effectively solves the problem that the citicoline sodium injection is unstable and easy to deteriorate during the production and storage process, reduces visible foreign matter and insoluble impurities in the injection, improves the quality of the drug, increases the safety and reliability of the citicoline sodium injection, makes up for the shortcomings of the prior art, and is suitable for modern production.

[0007] To achieve the above object, the present invention provides a citicoline sodium injection, the raw materials of which include citicoline sodium, an isotonic agent, a pH regulator and water for injection.

[0008] Preferably, each 1000 mL of the injection solution contains 130-132 g of citicoline sodium, 50-130 g of an isotonic agent, and the remainder is water for injection and a pH regulator.

[0009] Preferably, each 1000 mL of the injection solution contains 260-262 g of citicoline sodium, 50-130 g of an isotonic agent, and the remainder is water for injection and a pH regulator.

[0010] Preferably, the isotonic agent is selected from one or both of sorbitol and xylitol.

[0011] Further preferably, the sorbitol and xylitol are mixed in a weight ratio of 1-3:1.

[0012] Preferably, the pH adjuster is a dilute hydrochloric acid solution.

[0013] Preferably, the concentration of the dilute hydrochloric acid solution is 0.5-1 mol / L.

[0014] Preferably, the specifications of the citicoline sodium injection are 4mL:0.5g and 4mL:1g.

[0015] The present invention also provides a method for preparing the above-mentioned citicoline sodium injection, comprising the following steps:

[0016] (1) Add 65-75% of the total amount of water for injection into the liquid preparation tank, cool to 20-30° C., and fill with nitrogen below the liquid surface until the dissolved oxygen content is ≤1.0 mg / L to obtain liquid A;

[0017] (2) Continue stirring liquid A, add the prescribed amount of citicoline sodium and isotonic agent, and stir for 8-15 minutes to obtain liquid B;

[0018] (3) Continue stirring Liquid B, and adjust the pH value of Liquid B to 6.4-7.0 with a pH adjuster to obtain Liquid C;

[0019] (4) Add 20-30° C. water for injection to liquid C until the total amount of liquid is 1000 mL, turn on the nitrogen gas, and fill the liquid with nitrogen for 15-20 minutes while continuing to stir for 15-20 minutes until the mixture is uniform, thereby obtaining a crude solution of citicoline sodium;

[0020] (5) The crude solution of citicoline sodium is first pre-filtered once through a 0.45 μm cartridge filter element; then sterilized and filtered once through a 0.22 μm cartridge filter element (1); and then sterilized and filtered once through a 0.22 μm cartridge filter element (2) to obtain a citicoline sodium filtrate;

[0021] (6) Adjust the filling volume, fill the filtrate of citicoline sodium with nitrogen (control the residual oxygen content <5%) and then seal it; then sterilize it at 120-125° C. for 10-15 min, check it with a light to check for leaks, and package it to obtain citicoline sodium injection.

[0022] Preferably, the step (2) may also be: continue stirring liquid A, add the prescribed amount of citicoline sodium and isotonic agent, perform ultrasonic treatment at an ultrasonic frequency of 15-20 KHz for 8-15 min, and stir for 8-15 min to obtain liquid B.

[0023] Preferably, the material of the 0.45 μm cartridge filter in step (5) is hydrophilic polyvinylidene fluoride; and the material of the 0.22 μm cartridge filter (1) and the 0.22 μm cartridge filter (2) is polyethersulfone.

[0024] Beneficial effects of the present invention:

[0025] 1. Compared with the prior art, the present invention controls the temperature of the water for injection used for preparation, controls the dissolved oxygen level in the solution by nitrogen filling during the preparation process, and controls the headspace oxygen level in the packaging container by nitrogen filling during the filling process, thereby effectively controlling the oxygen content in the solution and keeping the oxygen content at a minimum.

[0026] 2. The present invention uses multiple filter elements to perform dilution and fine filtration, and with reasonable process parameter settings, it can effectively control pyrogens, microorganisms, endotoxins, etc. in the liquid medicine. At the same time, nitrogen is filled during the liquid medicine filling process to prevent the liquid medicine from being contaminated and oxidized during the production process. The impurity content in the prepared injection is low, which reduces the deterioration of the injection during storage and shows excellent stability.

[0027] 3. The present invention uses xylitol and sorbitol as isotonic agents, uses dilute hydrochloric acid to adjust the pH to 6.4-7.0, and uses ultrasonic treatment and filter materials of hydrophilic polyvinylidene fluoride and polyethersulfone to filter the crude solution of citicoline sodium in the preparation process of the injection, which can not only increase the solubility of citicoline sodium in water, but also effectively reduce the rising speed of related substances, improve the stability of citicoline sodium injection, and help to extend the storage time of citicoline sodium injection. In addition, the injection formula and unique preparation method used in the present invention can reduce visible foreign matter and insoluble impurities in the injection, which is beneficial to improve the quality of drugs and increase the safety of medication.

[0028] 4. The preparation process of the citicoline sodium injection of the present invention is simple, easy to operate, and suitable for large-scale production. DETAILED DESCRIPTION

[0029] The citicoline sodium injection provided by the present invention comprises raw materials including citicoline sodium, an isotonic agent, a pH regulator and water for injection; the isotonic agent is selected from one or both of sorbitol and xylitol; further, the sorbitol and xylitol are mixed at a weight ratio of 1-3:1; the pH regulator is a dilute hydrochloric acid solution; further, the concentration of the dilute hydrochloric acid solution is 0.5-1 mol / L.

[0030] The inventors have found that using sorbitol and xylitol as isotonic agents can not only help regulate the osmotic pressure of the injection, ensure that the drug safely and effectively enters the body to play a role, but also improve the stability of citicoline sodium in citicoline sodium injection. Sorbitol is a polyol with stable chemical properties and good thermal stability, and is not prone to oxidation and thermal decomposition; xylitol is a naturally occurring five-carbon sugar alcohol with good chemical stability and thermal stability, and is not prone to oxidation and thermal decomposition. Sorbitol and xylitol are added to citicoline sodium injection, which can extend its storage time and help maintain the long-term storage stability of the injection. In addition, the risk of producing 5-hydroxymethylfurfural during the long-term storage of the injection is reduced, and the safety and reliability of citicoline sodium injection are improved.

[0031] The specifications and raw material composition of the citicoline sodium injection are shown in Table 1:

[0032] Table 1

[0033]

[0034] The preparation method of citicoline sodium injection comprises the following steps:

[0035] (1) Add 65-75% of the total amount of water for injection into the liquid preparation tank, cool to 20-30° C., and fill with nitrogen below the liquid surface until the dissolved oxygen content is ≤1.0 mg / L to obtain liquid A;

[0036] (2) Liquid A is stirred continuously, and a prescribed amount of citicoline sodium and an isotonic agent are added, and the mixture is ultrasonically treated at an ultrasonic frequency of 15-20 kHz for 8-15 min while being stirred for 8-15 min to obtain Liquid B;

[0037] (3) Continue stirring Liquid B, and adjust the pH value of Liquid B to 6.4-7.0 with a pH adjuster to obtain Liquid C;

[0038] (4) Add 20-30° C. water for injection to liquid C until the total amount of liquid is 1000 mL, turn on the nitrogen gas, and fill the liquid with nitrogen for 15-20 minutes while continuing to stir for 15-20 minutes until the mixture is uniform, thereby obtaining a crude solution of citicoline sodium;

[0039] (5) The crude solution of citicoline sodium is first pre-filtered once through a 0.45 μm cartridge filter element; then sterilized and filtered once through a 0.22 μm cartridge filter element (1); and then sterilized and filtered once through a 0.22 μm cartridge filter element (2) to obtain a citicoline sodium filtrate;

[0040] (6) Adjust the filling volume, fill the filtrate of citicoline sodium with nitrogen (control the residual oxygen content <5%) and then seal it; then sterilize it at 120-125° C. for 10-15 min, check it with a light to check for leaks, and package it to obtain citicoline sodium injection.

[0041] The material of the 0.45 μm cartridge filter in step (5) is hydrophilic polyvinylidene fluoride; the material of the 0.22 μm cartridge filter (1) and the 0.22 μm cartridge filter (2) is polyethersulfone.

[0042] The present invention finds that in the process of preparing the injection, ultrasonic treatment of the liquid containing citicoline sodium and isotonic agent can increase the water solubility of citicoline sodium, and will not affect its drug activity, which is beneficial to increase the stability of citicoline sodium injection. Afterwards, hydrophilic polyvinylidene fluoride and polyether sulfone are selected as filter element materials, and the liquid is diluted and finely filtered through multiple filter elements, and reasonable process parameter settings are combined to effectively control pyrogens, microorganisms, and endotoxins in the liquid. The present invention avoids the use of auxiliary materials such as antibacterial agents, stabilizers, and cosolvents during the preparation process, as well as the use of activated carbon filtration, which not only reduces the possibility of introducing visible foreign matter and insoluble particles during the production process, increases drug safety, but also saves drug costs.

[0043] Example 1

[0044] A method for preparing citicoline sodium injection comprises the following steps:

[0045] (1) Add 70% of the total amount of water for injection into the liquid preparation tank, cool to 25° C., and fill with nitrogen below the liquid surface until the dissolved oxygen content is ≤1.0 mg / L to obtain liquid A;

[0046] (2) Liquid A was stirred continuously, and 130.63 g of citicoline sodium and 60 g of an isotonic agent were added, and the mixture was ultrasonically treated at an ultrasonic frequency of 18 kHz for 10 min while stirring for 10 min to obtain Liquid B;

[0047] (3) Liquid B is stirred continuously, and the pH value of Liquid B is adjusted to 6.5 with a dilute hydrochloric acid solution (1 mol / L) to obtain Liquid C;

[0048] (4) Add 25° C. water for injection to liquid C until the total amount of liquid is 1000 mL, turn on the nitrogen gas, and fill the liquid with nitrogen for 15 minutes while continuing to stir for 15 minutes until the mixture is uniform, thereby obtaining a crude solution of citicoline sodium;

[0049] (5) The crude solution of citicoline sodium is first pre-filtered once through a 0.45 μm cartridge filter element; then sterilized and filtered once through a 0.22 μm cartridge filter element (1); and then sterilized and filtered once through a 0.22 μm cartridge filter element (2) to obtain a citicoline sodium filtrate;

[0050] (6) Adjust the filling volume, fill the citicoline sodium filtrate with nitrogen (control the residual oxygen content <5%) and then seal it; then sterilize it at 121° C. for 12 min, check for leaks with a lamp, and package it to obtain the citicoline sodium injection.

[0051] The isotonic agent in step (2) is a mixture of 40 g sorbitol and 20 g xylitol.

[0052] The material of the 0.45 μm cartridge filter in step (5) is hydrophilic polyvinylidene fluoride; the material of the 0.22 μm cartridge filter (1) and the 0.22 μm cartridge filter (2) is polyethersulfone.

[0053] Example 2

[0054] A method for preparing citicoline sodium injection comprises the following steps:

[0055] (1) Add 70% of the total amount of water for injection into the liquid preparation tank, cool to 25° C., and fill with nitrogen below the liquid surface until the dissolved oxygen content is ≤1.0 mg / L to obtain liquid A;

[0056] (2) Liquid A was stirred continuously, and 261.25 g of citicoline sodium and 120 g of an isotonic agent were added, and the mixture was ultrasonically treated at an ultrasonic frequency of 18 kHz for 10 min while stirring for 10 min to obtain Liquid B;

[0057] (3) Liquid B is stirred continuously, and the pH value of Liquid B is adjusted to 6.5 with a dilute hydrochloric acid solution (1 mol / L) to obtain Liquid C;

[0058] (4) Add 25° C. water for injection to liquid C until the total amount of liquid is 1000 mL, turn on the nitrogen gas, and fill the liquid with nitrogen for 15 minutes while continuing to stir for 15 minutes until the mixture is uniform, thereby obtaining a crude solution of citicoline sodium;

[0059] (5) The crude solution of citicoline sodium is first pre-filtered once through a 0.45 μm cartridge filter element; then sterilized and filtered once through a 0.22 μm cartridge filter element (1); and then sterilized and filtered once through a 0.22 μm cartridge filter element (2) to obtain a citicoline sodium filtrate;

[0060] (6) Adjust the filling volume, fill the citicoline sodium filtrate with nitrogen (control the residual oxygen content <5%) and then seal it; then sterilize it at 121° C. for 12 min, check for leaks with a lamp, and package it to obtain the citicoline sodium injection.

[0061] The isotonic agent in step (2) is a mixture of 80 g of sorbitol and 40 g of xylitol.

[0062] The material of the 0.45 μm cartridge filter in step (5) is hydrophilic polyvinylidene fluoride; the material of the 0.22 μm cartridge filter (1) and the 0.22 μm cartridge filter (2) is polyethersulfone.

[0063] Example 3

[0064] A method for preparing citicoline sodium injection, which is different from Example 1 in that the isotonic agent in step (2) is 60g of sorbitol.

[0065] Example 4

[0066] A method for preparing citicoline sodium injection, which is different from Example 1 in that the isotonic agent in step (2) is 60g of xylitol.

[0067] Example 5

[0068] A method for preparing citicoline sodium injection comprises the following steps:

[0069] (1) Add 70% of the total amount of water for injection into the liquid preparation tank, cool to 25° C., and fill with nitrogen below the liquid surface until the dissolved oxygen content is ≤1.0 mg / L to obtain liquid A;

[0070] (2) Continue stirring liquid A, add 130.63 g of citicoline sodium and 60 g of isotonic agent, and stir for 10 min to obtain liquid B;

[0071] (3) Liquid B is stirred continuously, and the pH value of Liquid B is adjusted to 6.5 with a dilute hydrochloric acid solution (1 mol / L) to obtain Liquid C;

[0072] (4) Add 25° C. water for injection to liquid C until the total amount of liquid is 1000 mL, turn on the nitrogen gas, and fill the liquid with nitrogen for 15 minutes while continuing to stir for 15 minutes until the mixture is uniform, thereby obtaining a crude solution of citicoline sodium;

[0073] (5) The crude solution of citicoline sodium is first pre-filtered once through a 0.45 μm cartridge filter element; then sterilized and filtered once through a 0.22 μm cartridge filter element (1); and then sterilized and filtered once through a 0.22 μm cartridge filter element (2) to obtain a citicoline sodium filtrate;

[0074] (6) Adjust the filling volume, fill the citicoline sodium filtrate with nitrogen (control the residual oxygen content <5%) and then seal it; then sterilize it at 121° C. for 12 min, check for leaks with a lamp, and package it to obtain the citicoline sodium injection.

[0075] The isotonic agent in step (2) is a mixture of 40 g sorbitol and 20 g xylitol.

[0076] The material of the 0.45 μm cartridge filter in step (5) is hydrophilic polyvinylidene fluoride; the material of the 0.22 μm cartridge filter (1) and the 0.22 μm cartridge filter (2) is polyethersulfone.

[0077] Comparative Example 1

[0078] A method for preparing citicoline sodium injection, which is different from Example 1 in that the isotonic agent in step (2) is 60g of glucose.

[0079] Comparative Example 2

[0080] A method for preparing citicoline sodium injection, which differs from Example 1 in that the material of the 0.45 μm cartridge filter in step (5) is polypropylene; and the material of the 0.22 μm cartridge filter (1) and the 0.22 μm cartridge filter (2) is polyethersulfone.

[0081] Comparative Example 3

[0082] A method for preparing citicoline sodium injection, which differs from Example 1 in that the material of the 0.45 μm cartridge filter in step (5) is polytetrafluoroethylene; and the material of the 0.22 μm cartridge filter (1) and the 0.22 μm cartridge filter (2) is polyethersulfone.

[0083] Comparative Example 4

[0084] A method for preparing citicoline sodium injection, which differs from Example 1 in that the material of the 0.45 μm cartridge filter in step (5) is polyethersulfone; and the material of the 0.22 μm cartridge filter (1) and the 0.22 μm cartridge filter (2) is polyethersulfone.

[0085] Test Example 1

[0086] Test methods for each test item.

[0087] Stability test

[0088] The stability tests (accelerated tests and long-term tests) of the citicoline sodium glucose injections of Examples 1-5 and Comparative Examples 1-4 were respectively carried out, and the properties, pH value, content and related substances of the injections were tested in accordance with the quality standards of the Pharmacopoeia of the People's Republic of China (Part II, 2015 Edition) .

[0089] Accelerated test conditions and methods: The injection solutions prepared in Examples 1-5 and Comparative Examples 1-4 were respectively taken as test samples, and placed in a water-proof electric constant temperature incubator at a temperature of 50°C ± 1°C according to commercial packaging for 6 months. Then samples were taken and tested according to the main stability inspection items. The test results are shown in Table 2.

[0090] Long-term test conditions and methods: The injection solutions prepared in Examples 1-5 and Comparative Examples 1-4 were respectively taken as test samples, and placed in a water-insulated electric constant temperature incubator at a temperature of 25°C ± 2°C according to commercial packaging. Samples were taken once at the 6th, 12th and 24th months during the test period, and tested according to the main stability inspection items. The test results are shown in Table 2.

[0091] Table 2 Injection stability test results

[0092]

[0093]

[0094]

[0095] Analysis of the test results in Table 2 shows that, compared with Comparative Example 1 using glucose as an isotonic agent, the pH value and content of citicoline sodium injection in Examples 1-5 and Comparative Examples 2-4 using xylitol and sorbitol as isotonic agents are stable and have no significant changes, and the rising rate of related substances is slow, that is, the pH value, related substances, and content stability have obvious advantages; by comparing Example 1 with Examples 3-4, it is found that Example 1 using a combination of xylitol and sorbitol as an isotonic agent has a higher pH value, related substances, and content stability than Examples 3 and 4 using xylitol or sorbitol alone as an isotonic agent. The advantages are more obvious; by comparing Example 1 with Comparative Examples 2-4, it is found that in the preparation process of the injection solution, the crude preparation of citicoline sodium is filtered by filter elements made of hydrophilic polyvinylidene fluoride and polyethersulfone, respectively, compared with Comparative Example 2, in which the filter elements are polypropylene and polyethersulfone, Comparative Example 3, in which the filter elements are polytetrafluoroethylene and polyethersulfone, and Comparative Example 4, in which the filter elements are all polyethersulfone, the pH, related substances, and content stability are more obvious; by comparing Example 1 with Example 5, it is found that in the preparation process of the injection solution, Example 1, in which ultrasonic treatment is used, has more obvious advantages in pH, related substances, and content stability than Example 5, in which ultrasonic treatment is not used. Based on the above analysis of the stability of the injections of the embodiments and comparative examples, it is shown that the selection of xylitol and sorbitol as isotonic agents, the use of dilute hydrochloric acid to adjust the pH to 6.5, and the use of ultrasonic treatment and the selection of filter elements made of hydrophilic polyvinylidene fluoride and polyethersulfone to filter the crude solution of citicoline sodium during the preparation of the injection can not only increase the solubility of citicoline sodium in water, but also effectively reduce the rising rate of related substances, improve the stability of citicoline sodium injection, and help to prolong the storage time of citicoline sodium injection.

[0096] Test Example 2

[0097] Injection drug quality testing

[0098] According to the method of the Pharmacopoeia of the People's Republic of China (Volume 4 of the 2015 edition), the accelerated test was performed on Examples 1-2, Comparative Examples 2-4 and the commercially available Citicoline Sodium Injection (Chenxin Pharmaceutical Co., Ltd., specification 2ml: 0.25g, batch number 1906272262, national medicine standard H20055277), and the visible foreign matter and insoluble particles were detected. The test results are shown in Table 3. Among them, the accelerated test conditions and methods: the injection prepared by Examples 1-2 and Comparative Examples 2-4 and the commercially available Citicoline Sodium Injection (Huarun Shuanghe Limin Pharmaceutical (Jinan) Co., Ltd., specification 4mL: 0.5g, drug standard code: 86903973001305, national medicine standard H20237027) were taken as test samples, respectively, and placed in a water-insulated electric heating constant temperature incubator at a temperature of 50°C ± 1°C according to the commercially available packaging for 6 months, and then samples were taken to detect the visible foreign matter and insoluble particles.

[0099] Table 3 Quality inspection of injection drugs

[0100]

[0101]

[0102]

[0103] Analyzing the test result data in Table 3, it can be seen from the accelerated test results that the visible foreign matter and insoluble particles of Examples 1-2 of the present invention and Comparative Examples 2-4 all meet the standards and are superior to the commercially available Citicoline Sodium Injection, indicating that the injection formula and unique preparation method adopted by the present invention can reduce the visible foreign matter and insoluble impurities in the injection, which is beneficial to improving the quality of the drug and increasing the safety of medication. Comparing Example 1 with Comparative Examples 2-4, it is found that Example 1, in which the crude Citicoline Sodium solution is filtered using filter elements made of hydrophilic polyvinylidene fluoride and polyethersulfone, respectively, has less insoluble impurities than Comparative Example 2, in which the filter elements are made of polypropylene and polyethersulfone, respectively, Comparative Example 3, in which the filter elements are made of polytetrafluoroethylene and polyethersulfone, respectively, and Comparative Example 4, in which the filter elements are all made of polyethersulfone, and Example 1 has a more obvious advantage in reducing insoluble impurities.

Claims

1. A citicoline sodium injection, characterized in that: The raw materials include citicoline sodium, isotonic agent, pH regulator and water for injection.

2. The citicoline sodium injection according to claim 1, characterized in that: Each 1000 mL of the injection solution contains 130-132 g of citicoline sodium, 50-130 g of an isotonic agent, and the remainder is water for injection and a pH regulator.

3. The citicoline sodium injection according to claim 1, characterized in that: Each 1000 mL of the injection solution contains 260-262 g of citicoline sodium, 50-130 g of an isotonic agent, and the remainder is water for injection and a pH regulator.

4. The citicoline sodium injection according to any one of claims 1 to 3, characterized in that The isotonic agent is selected from one or both of sorbitol and xylitol; the sorbitol and xylitol are mixed in a weight ratio of 1-3:

1.

5. The citicoline sodium injection according to any one of claims 1 to 3, characterized in that The pH adjuster is a dilute hydrochloric acid solution.

6. The citicoline sodium injection according to claim 5, characterized in that: The concentration of the dilute hydrochloric acid solution is 0.5-1 mol / L.

7. The citicoline sodium injection according to any one of claims 1 to 6, characterized in that The specifications of the citicoline sodium injection are 4mL:0.5g and 4mL:1g.

8. The method for preparing citicoline sodium injection according to any one of claims 1 to 7, characterized in that: The following steps are involved: (1) Add 65-75% of the total amount of water for injection into the liquid preparation tank, cool to 20-30° C., and fill with nitrogen below the liquid surface until the dissolved oxygen content is ≤1.0 mg / L to obtain liquid A; (2) Continue stirring liquid A, add the prescribed amount of citicoline sodium and isotonic agent, and stir for 8-15 minutes to obtain liquid B; (3) Continue stirring Liquid B, and adjust the pH value of Liquid B to 6.4-7.0 with a pH adjuster to obtain Liquid C; (4) Add 20-30° C. water for injection to liquid C until the total amount of liquid is 1000 mL, turn on the nitrogen gas, and fill the liquid with nitrogen for 15-20 minutes while continuing to stir for 15-20 minutes until the mixture is uniform, thereby obtaining a crude solution of citicoline sodium; (5) The crude solution of citicoline sodium is first pre-filtered once through a 0.45 μm cartridge filter element; then sterilized and filtered once through a 0.22 μm cartridge filter element (1); and then sterilized and filtered once through a 0.22 μm cartridge filter element (2) to obtain a citicoline sodium filtrate; (6) Adjust the filling volume, fill the filtrate of citicoline sodium with nitrogen (control the residual oxygen content <5%) and then seal it; then sterilize it at 120-125° C. for 10-15 min, check it with a light to check for leaks, and package it to obtain citicoline sodium injection.

9. The method for preparing citicoline sodium injection according to claim 8, characterized in that: The step (2) may also be: continue stirring liquid A, add the prescribed amount of citicoline sodium and isotonic agent, perform ultrasonic treatment at an ultrasonic frequency of 15-20 KHz for 8-15 minutes, and stir for 8-15 minutes to obtain liquid B.

10. The method for preparing citicoline sodium injection according to claim 8, characterized in that: The material of the 0.45 μm cartridge filter in step (5) is hydrophilic polyvinylidene fluoride; the material of the 0.22 μm cartridge filter (1) and the 0.22 μm cartridge filter (2) is polyethersulfone.

Citation Information

Patent Citations

  • Citicoline sodium glucose injecta and preparation process thereof

    CN102144963A

  • Citicoline sodium injection and preparation method thereof

    CN111840220A

  • Pharmaceutical compositions comprising diphenylpyrazine derivatives

    CN116744903A

  • Preparation method of amikacin sulfate injection

    CN117618342A